Examining Chemotherapy–Radiation Sequencing for Uterine Cancer
“The optimal adjuvant therapy for women with advanced endometrial cancer remains controversial,”...
Jul 24, 2021
“The optimal adjuvant therapy for women with advanced endometrial cancer remains controversial,”...
Mar 19, 2020
Presently, there is no well-defined standard of care for managing pediatric patients with...
Aug 16, 2012
Recurrent and second primary head-and-neck squamous cell carcinomas (HNSCC) arising within or close to previously irradiated areas are a significant clinical challenge. Salvage surgical resection is the standard of care, but...
Mar 20, 2012
The FDA has approved glucarpidase (Voraxaze, BTG International) for treating patients with toxic levels of methotrexate—a type of chemotherapy—in the blood due to kidney failure. The drug breaks down methotrexate to a form that...
Sep 5, 2011
Colorectal cancer (CRC) is diagnosed in almost 150,000 patients in the United States each year and is the second leading cause of cancer-related death, accounting for more than 50,000 mortalities annually. The use of adjuvant...
Sep 21, 2010
A major challenge in treating ovarian cancer is that by the time most patients are diagnosed with the disease, it has already progressed to stage III or IV. The difficult-to-examine location of the ovaries deep in the pelvis...
Sep 14, 2010
Chemotherapy in the 21st century is only now beginning to evolve from its early, traumatic...
Aug 10, 2010
Chemotherapy-induced nausea and vomiting (CINV) remains a major adverse effect of cancer chemotherapy, despite the availability of several antiemetic drug classes. Although not life-threatening, CINV has a major impact on a...
Jul 20, 2010
The American Society of Clinical Oncology, or ASCO, held its 2010 annual meeting from June 4 to 8 in Chicago. The features below highlight some of the news emerging from the meeting. » A New Screening Strategy for Ovarian Cancer...